Primary Immune Deficiency Clinical Trial
Official title:
Primitive Immunodeficiency and Pregnancy
The management of patients with primary immune deficiency is increasingly codified, however contraception and pregnancy have not yet extensively studied or codified, and the medical monitoring and the prevention of infectious complications thus remains at the discretion of the practitioner. The aim the research is to study the obstetric features and outcome of patients with primary immune defects.
Primary immune deficiencies constitute a large group of immune system disorders of genetic origin which can associate, to varying degrees, an increased susceptibility to infections and immunopathological manifestations: allergy, inflammation, autoimmunity, lymphoproliferation, tumors malignant. Although their prevalence remains underestimated, there has been an increase in the number of cases diagnosed in the past 10 years. The national average prevalence is 8.6 patients per 100,000 inhabitants and the diagnostic incidence is 400 new cases per year in France. Major improvement in the management of primary immunodeficiencies have drastically changed patients outcome. Most patients now reach adulthood and the possibility of carrying out a pregnancy project, that has already reported for patients suffering from hypogammaglobulinemia or variable common immune deficiency, is now increasingly reported for other types of inherited immunodeficiencies. Whereas the management of patients with hereditary immunodeficiencies is increasingly codified, contraception and pregnancy have not yet been the subject of recommendations: medical monitoring and the prevention of infectious complications thus remain at the discretion of the practitioner. The aim the research is to study the obstetric experiences of patients with a primary immune deficiency, paying particular attention to infectious complications. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05321407 -
COVID-19 Vaccine Responses in PIDD Subjects
|
||
| Completed |
NCT01199705 -
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)
|
Phase 3 | |
| Recruiting |
NCT05070455 -
An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)
|
Phase 4 | |
| Recruiting |
NCT03836690 -
Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation
|
Phase 1 | |
| Completed |
NCT01461018 -
Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)
|
Phase 3 | |
| Recruiting |
NCT05476653 -
A Prospective Monocentric Study to Assess the Concordance of Lung MRI Compared to Chest CT Scan to Assess the Extent and Severity of Bronchial and Parenchymal Pulmonary Lesions in Adult Patients With Primary Immune Deficiency (PID) .
|
N/A | |
| Completed |
NCT00419341 -
Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy
|
Phase 3 | |
| Active, not recruiting |
NCT02868333 -
Determinants of Health Status and Quality of Life in Patients With Primary Immunodeficiencies Inhereted Diagnosed During Childhood
|
N/A | |
| Completed |
NCT01166074 -
Retrospective Chart Review of Subcutaneous IgG Use in Infants
|
N/A | |
| Recruiting |
NCT05932316 -
Evaluating Bronchodilator Response in Patients With Bronchiectasis
|
N/A | |
| Recruiting |
NCT04784364 -
Biologics And Clinical Immunology Cohort at Sinai
|
||
| Completed |
NCT06014463 -
Evaluation of Adult Patients With Immunodeficiency Within the Scope of the ICF
|
||
| Recruiting |
NCT04459689 -
COVID-19 in PID Survey
|
||
| Completed |
NCT02711228 -
Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules
|
Phase 4 | |
| Recruiting |
NCT04919018 -
Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies
|
||
| Completed |
NCT00719680 -
Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)
|
Phase 3 | |
| Terminated |
NCT00023504 -
Antibody Production in Immune Disorders
|
Phase 4 | |
| Recruiting |
NCT00246857 -
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
|
||
| Recruiting |
NCT04565015 -
Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
|
Phase 3 | |
| Recruiting |
NCT04702243 -
Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults
|